The phytological future of prostate cancer staging: PSMA-PET and the dandelion theory

Niranjan J. Sathianathen, Nicolas Geurts, Rajesh Nair, Nathan Lawrentschuk, Declan G. Murphy, Alastair D. Lamb

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


PSMA-PET is changing how we stage prostate cancer, both in the primary setting and with relapse after treatment. It allows us to identify lesions in the bones and lymph nodes that were not previously visible on conventional imaging with bone scan and CT/MRI. In this Special Report we review the 'state of the art' for PSMA imaging and discuss the implications for treatment decisions in prostate cancer. We liken early high risk or metastatic prostate to a common phytological problem: The dandelion. In this analogous situation, we consider the additional evidence needed for us to start plucking out the original dandelion and for us to focus attention on killing the seeded weeds that are identifiable elsewhere in the lawn.

Original languageEnglish (US)
Pages (from-to)1801-1807
Number of pages7
JournalFuture Oncology
Issue number20
StatePublished - Aug 2017

Bibliographical note

Funding Information:
DG Murphy and N Lawrentschuk are both principal investigators for the ProPSMA study (HREC/16/ PMCC/130), which is funded by the Movember Foundation. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Publisher Copyright:
© 2017 2017 Future Medicine Ltd.


  • metastasis
  • PET
  • prostate cancer
  • PSMA
  • staging

PubMed: MeSH publication types

  • Journal Article
  • Review


Dive into the research topics of 'The phytological future of prostate cancer staging: PSMA-PET and the dandelion theory'. Together they form a unique fingerprint.

Cite this